摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-dimethylamino-6-methyl-pyrimidine-4-carboxylic acid | 1018648-19-5

中文名称
——
中文别名
——
英文名称
2-dimethylamino-6-methyl-pyrimidine-4-carboxylic acid
英文别名
2-(Dimethylamino)-6-methylpyrimidine-4-carboxylic acid
2-dimethylamino-6-methyl-pyrimidine-4-carboxylic acid化学式
CAS
1018648-19-5
化学式
C8H11N3O2
mdl
MFCD10032942
分子量
181.194
InChiKey
FQUBTCRHHXVCTJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    369.1±34.0 °C(Predicted)
  • 密度:
    1.269±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.375
  • 拓扑面积:
    66.3
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES
    申请人:Bolli Martin
    公开号:US20110046170A1
    公开(公告)日:2011-02-24
    The invention relates to novel pyrimidine-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    本发明涉及新颖的嘧啶-吡啶衍生物、其制备方法及其作为药理活性化合物的应用。这些化合物特别作为免疫调节剂发挥作用。
  • NOVEL PYRIMIDINE DERIVATIVES
    申请人:Bolli Martin
    公开号:US20100234346A1
    公开(公告)日:2010-09-16
    The invention relates to novel pyrimidine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents Formula (II), Formula (III), Formula (IV), Formula (V), Formula (VI), Formula (VII), Formula (VIII) or Formula (IX)
    这项发明涉及新型嘧啶生物,它们的制备以及它们作为药用活性化合物的用途。这些化合物特别作为免疫调节剂。公式(I)其中A代表公式(II)、公式(III)、公式(IV)、公式(V)、公式(VI)、公式(VII)、公式(VIII)或公式(IX)。
  • [EN] NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS DE PYRIMIDINE-PYRIDINE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2009109907A1
    公开(公告)日:2009-09-11
    The invention relates to novel pyrimidine-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula I.
    本发明涉及新颖的嘧啶-吡啶衍生物、其制备方法及其作为药理活性化合物的应用。所述化合物特别作为免疫调节剂发挥作用。式I。
  • [EN] ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS<br/>[FR] COMPOSÉS URÉE HÉTÉROCYCLIQUES SUBSTITUÉS PAR AMIDE ET SULFONAMIDE ANTIBACTÉRIENS
    申请人:REPLIDYNE INC
    公开号:WO2009015208A1
    公开(公告)日:2009-01-29
    The present invention provides novel amide and sulfonamide substituted heterocyclic urea compounds having useful antibacterial activity. Use of these compounds as pharmaceutical compositions and method of their production are also provided.
    本发明提供了具有有用抗菌活性的新型酰胺和磺胺基取代的杂环化合物。同时还提供了将这些化合物用作药物组合物以及它们的生产方法。
  • 1-[M-CARBOXAMIDO(HETERO)ARYL-METHYL]-PIPERIDINE-4-CARBOXAMIDE DERIVATIVES
    申请人:FRETZ Heinz
    公开号:US20130345199A1
    公开(公告)日:2013-12-26
    The present invention relates to 1-[m-Carboxamido(hetero)aryl-methyl]-piperidine-4-carboxamide derivatives of formula (I) wherein X, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 5 and p are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.
    本发明涉及公式(I)中的1-[m-羧酰胺(杂)芳基甲基]-哌啶-4-羧酰胺衍生物,其中X、Ar1、R1、R2、R3、R4、R5和p如描述中所述,以及其制备方法,其药学上可接受的盐,以及其作为药物的用途,包括含有一个或多个公式(I)化合物的药物组合物,特别是其作为CXCR7受体调节剂的用途。
查看更多